CNS Research, Inc. Phone: 1-800-***-****
Email: abpjyx@r.postjobfree.com
East Providence, RI 02906
Fax 1-800-***-****
PATRICIA T. SCHUMACHER, RN, BSN
PROFESSIONAL EXPERIENCE
30 years RN with depth of health care experience in critical care, research, performance improvement,
elder care, health care systems and a Certified Legal Nurse Consultant. Proven ability in thousands of
medical record reviews, research data abstraction, standards identification, complex medical-surgical
assessments, and development of interventions to improve clinical outcomes and analysis of physical and
psychosocial responses to health alterations. Recognized expertise as a clinical resource and consumer
advocate.
07/02 - Present CNS Research, Inc. Providence, RI
Research Coordinator
Responsible for Patient recruitment
Screening patients for inclusion and exclusion criteria
Managing the conduct of research trials
AFFILIATIONS
CNS Research, Inc. 450 Veterans Memorial Parkway #11
East Providence, RI 02914
814 Metacom Ave, Bristol, RI 02809
CNS Research, Inc. 360 Kingstown Rd Unit 102
Narragansett, RI 02882-3239
EXPERIENCE HIGHLIGHTS
Formally recognized for conducting comprehensive national elder care study (ACOVE) in
association with RAND for a national health insurance provider, achieving a 96% response rate, and
nationwide diabetic eye-care study. Performed medical record abstractions and data collection for multiple
clinical drug studies for FDA and pharmaceutical firm in association with Rand.
Evaluated data collection tools proposing changes for specificity and clarity applicable to clinical
situations. Educated research participants increasing the acquisition of data. Identified standards
documentation/compliance using retrospective in-patient and physician site-based reviews.
Audited medical records for HEDIS data collection, NCQA accreditation, physician credentialing
and behavioral health appeals and denials. Employed root cause analysis to identify barriers and develop
interventions to improve HEDIS outcome data, establish guidelines to improve end-of-life care, and
develop care standards for the critically chronically ill patient.
Developed evidence based pain management policy and procedures to comply with JCAHO
standards for a community health care agency improving staff competencies. Contributed to multi-
discipline panel discussion for Rights of the Dying video for ACLU to raise consumer awareness. Co-
founded a Nursing Ethics Committee in a 100-bed community hospital instrumental in the development of
a Limitations-of -Therapy policy.
CNS Research: The information contained in this document is confidential.
Page 1 Patricia T. Schumacher, RN
Educated patients and caregivers about health maintenance, disease management, recovery
strategies, and self-advocacy skills improving patient outcomes. Designed plans of care providing symptom
management/therapeutic care employing advanced invasive technologies, life-support interventions,
infusion therapies, and complex medication regimes in critical care, post anesthesia care units, emergency
departments, and home care settings.
EDUCATION
CCRC 2007 2990 ACRP Certification
Bachelor of Science 1993 University of Rhode Island, Kingston, RI
RN Diploma of Nursing 1972 Massachusetts General Hospital, Boston, MA
CREDENTIALS
RN 16959-Rhode Island
Certified Legal Nurse Consultant
Advanced/Basic Cardiac life Support
National Critical Care Certification
National Alliance of Legal Nurse Consultants
American Association of Critical Care Nurses
Nursing Pain Advocacy Community
Sigma Theta Tau Nursing Honor Society
Intravenous Nurses Association
RESEARCH EXPERIENCE
A Prospective, 26-Week, Open-label, Single-arm, Multicenter Study Evaluating the Efficacy and
Safety of Exelon (rivastigmine tartrate) 3-12 mg/day in Patients with Mild to Moderate Alzheimer's
Disease Who Are Responding Poorly to Aricept (donepezil) Treatment.
Protocol MTX-M3, A Multicenter, Randomized, Placebo-controlled, Double-blind,
Parallel-group Trial to Evaluate Early Efficacy and Tolerability of ZICAM Migraine.
Nasal Spray in the Acute Treatment of Adult Subjects with Migraine.
Protocol No. 0912A2-212-NA, Multicenter, Randomized, Double-Blind, Placebo-
Controlled, Parallel-Group Study of 3 Fixed Doses of EAA-090 in Adult Outpatients
With Neuropathic Pain Associated With Diabetic Neuropathy.
Protocol # SNK-860-201: A Phase 2 Randomized, Double-Blind, Placebo-Controlled,
Trial of Fidarestat (SNK-860) 9 mg and 30 mg in Patients with Diabetic Polyneuropathy.
Protocol CL 758007: Phase III Study of the Efficacy and Safety of
Alzhemed in Patients with Mild to Moderate Alzheimer s Disease
Premere PFO Closure System for the Effect of Septal Closure of Atrial PFO on Events of Migraine with
Remere (ESCAPE Migraine) Trial.
Novartis Pharmaceuticals Protocol No.: CFTY720DUS01
A 6-month, Randomized, Active Comparator, Open-label, Multi- Center Study to Evaluate Patient
OutComes, Safety and Tolerability of Fingolimod 0.5 mg/day in Patients with Relapsing Forms of
Multiple Sclerosis who are candidates for MS therapy change from Previous Disease Modifying
Therapy (EPOC)
CNS Research: The information contained in this document is confidential.
Page 2 Patricia T. Schumacher, RN